Featured Research

from universities, journals, and other organizations

Endoscopy-based early enterostomy closure

Date:
March 5, 2010
Source:
World Journal of Gastroenterology
Summary:
A research team from Japan retrospectively studied 15 patients who underwent massive bowel resection with enterostomy for superior mesenteric arterial occlusion (SMAO) to evaluate the efficacy of endoscopic examination of blood flow and edema in the remnant bowel. Their results showed endoscopic examination is useful to assess the feasibility of early closure of enterostomy in SMAO cases.

It is generally recommended that a temporary stoma be closed within 9-12 wk after its construction. However, because some patients poorly tolerate the temporary stoma owing to extracellular dehydration, difficult pouch fitting, parenteral nutrition requirement in cases when the stoma is very proximal, and psychological or social impact, it might be advisable to opt for early closure.

In order to assess the feasibility of early closure and its outcome, a research team from Japan endoscopically inspected blood flow and edema in the remnant bowel of stoma patients and defined a minimal delay as optimal for closing small bowel stomas. Their study was published on February 28, 2010 in the World Journal of Gastroenterology.

Fifteen patients who underwent massive bowel resection with enterostomy for superior mesenteric arterial occlusion (SMAO) were divided into a delayed closure group (D group) and an early closure group (E group). It was found that the mean duration from initial operation to enterostomy closure was significantly shorter in the E group (18.3 2.1 d) than in the D group (34.3 5.9 d). The duration of hospitalization after surgery was significantly shorter in the E group (33 2.2 d) than in the D group (51 8.9 d).

They concluded that endoscopic examination of blood flow and edema in the remnant bowel is a useful predictor to determine the time of enterostomy closure in SMAO cases.


Story Source:

The above story is based on materials provided by World Journal of Gastroenterology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Oida T, Kano H, Mimatsu K, Kawasaki A, Kuboi Y, Fukino N, Amano S. Endoscopy-based early enterostomy closure for superior mesenteric arterial occlusion. World Journal of Gastroenterology, 2010; 16 (8): 992 DOI: 10.3748/wjg.v16.i8.992

Cite This Page:

World Journal of Gastroenterology. "Endoscopy-based early enterostomy closure." ScienceDaily. ScienceDaily, 5 March 2010. <www.sciencedaily.com/releases/2010/03/100305112355.htm>.
World Journal of Gastroenterology. (2010, March 5). Endoscopy-based early enterostomy closure. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/03/100305112355.htm
World Journal of Gastroenterology. "Endoscopy-based early enterostomy closure." ScienceDaily. www.sciencedaily.com/releases/2010/03/100305112355.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins